Mauro Ferrari (original) (raw)

dbo:abstract

ماورو فيراري (بالإيطالية: Mauro Ferrari)‏ هو عالم إيطالي، ولد في 1959 في أوديني في إيطاليا. (ar)
Mauro Ferrari (Padua, 7 de julio de 1959) es un profesor y científico italiano. Experto en el campo de la nanotecnología y de la bioingeniería aplicada a la medicina, ha sido presidente y CEO del Houston Methodist Research Institute, director del Institute of Academic Medicine del Methodist Hospital System (TMHS) y presidente de The Alliance for NanoHealth. En enero de 2020 fue nombrado presidente del Consejo Europeo de Investigación, cargo del que dimitió en abril de 2020 por la crisis del coronavirus. (es)
Mauro Ferrari (born 7 July 1959) is a nanoscientist and leader in the field of nanomedicine. He served as special expert on nanotechnology for the National Cancer Institute (2003-2005) and was instrumental in establishing the Alliance for Nanotechnology in Cancer in 2004.On 1 January 2020, Ferrari was made president of the European Research Council (ERC). Following a vote of no confidence, on 27 March 2020, "all 19 active members of the ERC’s Scientific Council individually and unanimously requested that Mauro Ferrari resign from his position as ERC’s President", due to poor conduct in office, exploiting the position to further his own projects, and for consistently failing to represent the interests of the ERC. On 7 April 2020, Ferrari officially resigned, stating to the media that he was "extremely disappointed by the European response” to the pandemic and expressing frustration over opposition to his efforts to launch a scientific program to combat the virus. (en)
Mauro Ferrari (Udine, 7 luglio 1959) è un accademico bioingegnere e ricercatore italiano, impegnato principalmente nella ricerca sulle nanotecnologie e nel campo della bioingegneria applicate in medicina. È presidente e CEO del Houston Methodist Research Institute, direttore dal 2013 dell'Institute of Academic Medicine del Methodist Hospital System ed Executive Vice President del Methodist Hospital System (TMHS). È presidente della The Alliance for NanoHealth. (it)

dbo:academicDiscipline

dbr:Nanomedicine

dbo:almaMater

dbo:award

dbo:birthDate

1959-07-07 (xsd:date)

dbo:birthPlace

dbr:Padova

dbo:institution

dbo:knownFor

dbo:wikiPageExternalLink

dbo:wikiPageID

53330934 (xsd:integer)

dbo:wikiPageLength

30518 (xsd:nonNegativeInteger)

dbo:wikiPageRevisionID

1120429960 (xsd:integer)

dbo:wikiPageWikiLink

dbp:almaMater

(en)
University of California Berkeley MS, PhD (en)
University of Padova, Italy Dottore, Mathematics) (en)

dbp:birthDate

1959-07-07 (xsd:date)

dbp:birthPlace

Padova, Italy (en)

dbp:caption

Mauro Ferrari in 2010 (en)

dbp:children

five (en)

dbp:field

dbr:Nanomedicine

dbp:knownFor

Bioethics (en)
Nanomedicine (en)
(en)
Drug delivery (en)
Nanofluidics (en)
Biomedical microtechnology (en)
Cancer Therapeutics (en)

dbp:name

Mauro Ferrari (en)

dbp:nationality

Italy, United States (en)

dbp:prizes

(en)
Fellow, American Association for the Advancement of Science (en)
Aurel Stodola Medal (en)
Blaise Pascal Medal in Biomedical Engineering (en)
Department of Defense Innovator Award (en)
National Academy of Sciences Europe (en)
National Academy of Sciences Italy (en)

dbp:spouse

1995 (xsd:integer)
(en)
Paola Ferrari (en)

dbp:website

http://www.houstonmethodist.org/research/our-faculty/labs/ferrari-lab/

dbp:wikiPageUsesTemplate

dbp:workplaces

Ohio State University (en)
University of Texas (en)
(en)
National Cancer Institute (en)
University of California Berkeley (en)
Houston Methodist (en)

dct:subject

schema:sameAs

http://viaf.org/viaf/42147404

rdf:type

rdfs:comment

ماورو فيراري (بالإيطالية: Mauro Ferrari)‏ هو عالم إيطالي، ولد في 1959 في أوديني في إيطاليا. (ar)
Mauro Ferrari (Padua, 7 de julio de 1959) es un profesor y científico italiano. Experto en el campo de la nanotecnología y de la bioingeniería aplicada a la medicina, ha sido presidente y CEO del Houston Methodist Research Institute, director del Institute of Academic Medicine del Methodist Hospital System (TMHS) y presidente de The Alliance for NanoHealth. En enero de 2020 fue nombrado presidente del Consejo Europeo de Investigación, cargo del que dimitió en abril de 2020 por la crisis del coronavirus. (es)
Mauro Ferrari (Udine, 7 luglio 1959) è un accademico bioingegnere e ricercatore italiano, impegnato principalmente nella ricerca sulle nanotecnologie e nel campo della bioingegneria applicate in medicina. È presidente e CEO del Houston Methodist Research Institute, direttore dal 2013 dell'Institute of Academic Medicine del Methodist Hospital System ed Executive Vice President del Methodist Hospital System (TMHS). È presidente della The Alliance for NanoHealth. (it)
Mauro Ferrari (born 7 July 1959) is a nanoscientist and leader in the field of nanomedicine. He served as special expert on nanotechnology for the National Cancer Institute (2003-2005) and was instrumental in establishing the Alliance for Nanotechnology in Cancer in 2004.On 1 January 2020, Ferrari was made president of the European Research Council (ERC). Following a vote of no confidence, on 27 March 2020, "all 19 active members of the ERC’s Scientific Council individually and unanimously requested that Mauro Ferrari resign from his position as ERC’s President", due to poor conduct in office, exploiting the position to further his own projects, and for consistently failing to represent the interests of the ERC. On 7 April 2020, Ferrari officially resigned, stating to the media that he was (en)

rdfs:label

ماورو فيراري (ar)
Mauro Ferrari (es)
Mauro Ferrari (it)
Mauro Ferrari (en)

owl:sameAs

prov:wasDerivedFrom

wikipedia-en:Mauro_Ferrari?oldid=1120429960&ns=0

foaf:homepage

http://www.houstonmethodist.org/research/our-faculty/labs/ferrari-lab/

foaf:isPrimaryTopicOf

wikipedia-en:Mauro_Ferrari

foaf:name

Mauro Ferrari (en)

is dbo:doctoralAdvisor of

dbr:Tejal_A._Desai

is dbo:wikiPageWikiLink of

is dbp:doctoralAdvisor of

dbr:Tejal_A._Desai

is foaf:primaryTopic of

wikipedia-en:Mauro_Ferrari